CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...